NFATC3 and cardiac hypertrophy: Among the predicted potential targets of miR-145-5p, we focused on Nfatc3, because it is the main effector molecule downstream of calcineurin (CaN) in the heart, which is essential for the development of cardiac hypertrophy (Sassi et al., 2017; Altamirano et al., 2009).